Showing results (2111-2120 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|December 17, 2020
Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Locally Advanced Non-small Cell Lung CancerXiaojun Wang, Huiyun Zhang, Liangfen Zhou, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 4, 2021
Pinocembrin Inhibits the Proliferation, Migration, Invasiveness, and Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Regulating LACTBLai Jiang, Yongbo Yang, Haiyang Feng, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 14, 2020
Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1Wenjie Zhang, Wei Hong
Cancer Biotherapy & Radiopharmaceuticals|December 9, 2022
Philosophy of Cancer TheranosticsJ Harvey Turner
Cancer Biotherapy & Radiopharmaceuticals|February 20, 2020
Alpha-Particle Therapy for Multifocal Osteosarcoma: A HypothesisJanina Baranowska-Kortylewicz, John G Sharp, Timothy R McGuire, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 21, 2020
Realizing Clinical Trials with Astatine-211: The Chemistry InfrastructureSture Lindegren, Per Albertsson, Tom Bäck, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 16, 2022
Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor OverexpressionSreeja Raj Menon, Arpit Mitra, Avik Chakraborty, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 21, 2021
MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular CarcinomaChao Yang, Peng Du, Wei Lu
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2021
Overexpression of circRNA circFAT1 in Endometrial Cancer Cells Increases Their Stemness by Upregulating miR-21 Through MethylationWeiwei Wu, Jianqing Zhou, Yan Wu, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 13, 2022
miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B SignalingJing Ma, Sijia Na, Panxi Wang, et al.
Pageof 224